Impairment of circulating endothelial progenitors in Down syndrome

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  Costa, Valerio ^a   Sommese, Linda ^b   Casamassimi, Amelia ^b   Colicchio, Roberta ^c   Angelini, Claudia ^d   Marchesano, Valentina ^e   Milone, Lara ^b   Farzati, Bartolomeo ^b   Giovane, Alfonso ^b   Fiorito, Carmela ^f   Rienzo, Monica ^b   Picardi, Marco ^e   Avallone, Bice ^e   Marco Corsi, Massimiliano ^g   Sarubbi, Berardo ^b   Calabr, Raffaele ^b   Salvatore, Paola ^e   Ciccodicola, Alfredo ^a   Napoli, Claudio ^b  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c IRCCS SDN   (Italy)

^d CNR   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f IRCCS MULTIMEDICA   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR B; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENE PRODUCT; HYDROPEROXIDE; HYPOCALCIN; INTERFERON STIMULATED GENE FACTOR 20; INTERLEUKIN 8; JANUS KINASE; MEMBRANE RECEPTOR; PROTEIN HSA21; PROTEIN RCAN1; PROTEIN S100B; STANNIOCALCIN 1; STAT PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN A; HYDROGEN PEROXIDE; STROMAL CELL DERIVED FACTOR 1;

ADULT; ANGIOGENESIS; ARTICLE; BARTONELLA HENSELAE; BARTONELLOSIS; BIOINFORMATICS; CELL COUNT; CELL FUNCTION; CELL SIZE; CELL STRUCTURE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN SYNDROME; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION SENSITIVITY; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TRANSMISSION ELECTRON MICROSCOPY; TRISOMY 21; BLOOD; CAT SCRATCH DISEASE; CHROMOSOME 21; CYTOLOGY; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE; TRISOMY; VASCULAR ENDOTHELIUM;

BARTONELLA HENSELAE;

CAT-SCRATCH DISEASE; CHEMOKINE CXCL12; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; ENDOTHELIUM, VASCULAR; HUMANS; HYDROGEN PEROXIDE; OXIDATIVE STRESS; PHENOTYPE; STEM CELLS; TRISOMY;

EID: 77956481391     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-40     Document Type: Article

References (59)

1. Down syndrome - recent progress and future prospects. FK Wiseman KA Alford VL Tybulewicz EM Fisher, Hum Mol Genet 2009 18 75 83 10.1093/hmg/ddp010 18826963
2. Islet autoimmunity in children with Down's syndrome. KM Gillespie RJ Dix AJ Williams R Newton ZF Robinson PJ Bingley EA Gale JP Shield, Diabetes 2006 55 3185 3188 10.2337/db06-0856 17065360
3. Immunology of Down syndrome: a review. AG Ugazio R Maccario LD Notarangelo GR Burgio, Am J Med Genet Suppl 1990 7 204 212 2149949
4. Risk of death for children with down syndrome and sepsis. MM Garrison H Jeffries DA Christakis, J Pediatr 2005 147 748 752 10.1016/j.jpeds.2005.06.032 16356424
5. Angiogenesis: an organizing principle for drug discovery? J Folkman, Nat Rev Drug Discov 2007 6 273 286 10.1038/nrd2115 17396134 (Pubitemid 46505878)
6. Risks of leukaemia and solid tumours in individuals with Down's syndrome. H Hasle IH Clemmensen M Mikkelsen, Lancet 2000 355 165 169 10.1016/S0140- 6736(99)05264-2 10675114
7. Diabetic retinopathy in Down's syndrome. T Fulcher M Griffin S Crowley R Firth R Acheson N O' Meara, Br J Ophthalmol 1998 82 407 409 10.1136/bjo.82.4.407 9640190
8. Endothelial cell function in patients with Down's syndrome. M Cappelli-Bigazzi G Santoro C Battaglia MT Palladino M Carrozza MG Russo G Pacileo R Calabr Am J Cardiol 2004 94 392 395 10.1016/j.amjcard.2004.04.047 15276117
9. Transcriptome analysis of human autosomal trisomy. DR FitzPatrick J Ramsay NI McGill M Shade AD Carothers ND Hastie, Hum Mol Genet 2002 11 3249 3256 10.1093/hmg/11.26.3249 12471051
10. Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. R Mao CL Zielke HR Zielke J Pevsner, Genomics 2003 81 457 467 10.1016/S0888-7543(03)00035-1 12706104
11. Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. CM Li M Guo M Salas N Schupf W Silverman WB Zigman S Husain D Warburton H Thaker B Tycko, BMC Med Genet 2006 7 24 10.1186/1471-2350-7-24 16539728
12. Identification of dysregulated genes in lymphocytes from children with Down syndrome. CA Sommer EC Pavarino-Bertelli EM Goloni-Bertollo F Henrique-Silva, Genome 2008 51 19 29 10.1139/G07-100 18356936
13. Gene-dosage effects in Down syndrome and trisomic mouse models. K Gardiner, Genome Biol 2004 5 244 10.1186/gb-2004-5-10-244 15461808
14. The challenge of Down syndrome. SE Antonarakis CJ Epstein, Trends Mol Med 2006 12 473 479 10.1016/j.molmed.2006.08.005 16935027
15. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. MC Yoder LE Mead D Prater TR Krier KN Mroueh F Li R Krasich CJ Temm JT Prchal DA Ingram, Blood 2007 109 1801 1809 10.1182/blood-2006-08-043471 17053059
16. Assessing identity, phenotype, and fate of endothelial progenitor cells. KK Hirschi DA Ingram MC Yoder, Arterioscler Thromb Vasc Biol 2008 28 1584 1595 10.1161/ATVBAHA.107.155960 18669889
17. Vascular Repair by Endothelial Progenitor Cells. A Zampetaki JP Kirton Q Xu, Cardiovascular Research 2008 78 413 421 10.1093/cvr/cvn081 18349136
18. Endothelial progenitor cell-based neovascularization: implications for therapy. G Krenning MJ van Luyn MC Harmsen, Trends Mol Med 2009 15 180 189 10.1016/j.molmed.2009.02.001 19303359
19. Endothelial progenitor cells in cardiovascular disorders. E Shantsila T Watson GY Lip, Journal of the American College of Cardiology 2007 49 741 752 10.1016/j.jacc.2006.09.050 17306702
20. Number and migratory activity of circulating andothelial progenitor cells inversely correlate with risk factors for coronary artery disease. M Vasa S Fichtlscherer A Aicher K Adler C Urbich H Martin AM Zeiher S Dimmeler, Circulation Research 2001 89 1 7 10.1161/hh1301.093953 11440984
21. Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. F Sabatier L Camoin-Jau F Anfosso J Sampol F Dignat-George, J Cell Mol Med 2009 13 454 471 10.1111/j.1582-4934.2008.00639.x 19379144
22. Hematopoietic progenitor cell deficiency in fetuses and children affected by Down's syndrome. DK Holmes N Bates M Murray EJ Ladusans A Morabito PH Bolton-Maggs TA Johnston S Walkenshaw RF Wynn I Bellantuono, Exp Hematol 2006 34 1611 1615 10.1016/j.exphem.2006.10.013 17157155
23. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. GP Diller S van Eijl DO Okonko LS Howard O Ali T Thum SJ Wort E Bédard JS Gibbs J Bauersachs AJ Hobbs MR Wilkins MA Gatzoulis J Wharton, Circulation 2008 117 3020 3030 10.1161/CIRCULATIONAHA.108.769646 18519847
24. The growth capacity of bone marrow CD34 positive cells in culture is drastically reduced in a murine model of Down syndrome. B Jablonska D Ford D Trisler B Pessac, C R Biol 2006 329 726 732 10.1016/j.crvi.2006.06.004 16945839
25. Endothelial activation by cytokines. A Mantovani S Sozzani M Introna, Ann N Y Acad Sci 1997 832 93 116 10.1111/j.1749-6632.1997.tb46240.x 9704040
26. Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells. P Salvatore A Casamassimi L Sommese C Fiorito A Ciccodicola R Rossiello B Avallone V Grimaldi V Costa M Rienzo R Colicchio S Williams-Ignarro C Pagliarulo ME Prudente C Abbondanza F Lamberti A Baroni E Buommino B Farzati MA Tufano LJ Ignarro C Napoli, Proc Natl Acad Sci USA 2008 105 9427 9432 10.1073/pnas.0803602105 18595894
27. Bartonella-host-cell interactions and vascular tumour formation. C Dehio, Nat Rev Microbiol 2005 3 621 631 10.1038/nrmicro1209 16064054
28. Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-alpha/beta. S Kunz K Oberle A Sander C Bogdan U Schleicher, Am J Pathol 2008 172 1005 1018 10.2353/ajpath.2008.070591 18292236
29. Age-related changes in plasma levels of BDNF in Down syndrome patients. G Dogliotti E Galliera F Licastro MM Corsi, Immun Ageing 2010 7 2 10.1186/1742-4933-7-2 20181009
30. Comparison between total endothelial progenitor cell isolation versus enriched CD133+ culture. A Casamassimi ML Balestrieri C Fiorito C Schiano C Maione R Rossiello V Grimaldi V Del Giudice C Balestrieri B Farzati V Sica C Napoli, J Biochem 2007 141 503 511 10.1093/jb/mvm060 17308344
31. Evidence for hair cell regeneration in the crista ampullaris of the lizard Podarcis sicula. B Avallone M Porritiello D Esposito R Mutone G Balsamo F Marmo, Hear Res 2003 178 79 88 10.1016/S0378-5955(03)00040-6 12684180
32. Identification and expression analysis of novel Jakmip1 transcripts. V Costa I Conte C Ziviello A Casamassimi G Alfano S Banfi A Ciccodicola, Gene 2007 402 1 8 10.1016/j.gene.2007.07.001 17761393
33. Identifying biological themes within lists of genes with EASE. DA Hosack G Dennis Jr BT Sherman HC Lane RA Lempicki, Genome Biol 2003 4 70 10.1186/gb-2003-4-10-r70 14519205
34. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. W Huang da BT Sherman RA Lempicki, Nat Protoc 2009 4 44 57 10.1038/nprot.2008.211 19131956
35. PANTHER: a library of protein families and subfamilies indexed by function. PD Thomas MJ Campbell A Kejariwal H Mi B Karlak R Daverman K Diemer A Muruganujan A Narechania, Genome Res 2003 13 2129 2141 10.1101/gr.772403 12952881
36. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. E Dernbach C Urbich RP Brandes WK Hofmann AM Zeiher S Dimmller, Blood 2004 104 3591 3597 10.1182/blood-2003-12-4103 15161665
37. Bartonella-associated endothelial proliferation depends on inhibition of apoptosis. JE Kirby DM Nekorchuk, Proc Natl Acad Sci USA 2002 99 4656 4661 10.1073/pnas.072292699 11904386
38. Bartonella henselae: subversion of vascular endothelial cell functions by translocated bacterial effector proteins. AT Pulliainen C Dehio, Int J Biochem Cell Biol 2009 41 507 510 10.1016/j.biocel.2008.10.018 19010441
39. Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. G Esposito J Imitola J Lu D De Filippis C Scuderi VS Ganesh R Folkerth J Hecht S Shin T Iuvone J Chesnut L Steardo V Sheen, Hum Mol Genet 2008 17 440 457 10.1093/hmg/ddm322 17984171
40. Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis. M Lee D Hyun P Jenner B Halliwell, J Neurochem 2001 76 957 965 10.1046/j.1471-4159.2001.00107.x 11181815
41. Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regions. K De Preter R Barriot F Speleman J Vandesompele Y Moreau, Nucleic Acids Res 2008 36 43 10.1093/nar/gkn114 18346969
42. Endothelial progenitor cells mobilization differentiation and homing. M Hristov W Wolfgang PC Weber, Arterioscler Thromb Vasc Biol 2003 23 1185 1189 10.1161/01.ATV.0000073832.49290.B5 12714439
43. Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. CG Egan R Lavery F Caporali C Fondelli F Laghi-Pasini F Dotta V Sorrentino, Diabetologia 2008 51 1296 1305 10.1007/s00125-008-0939-6 18286257
44. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. C Schmidt-Lucke L Rössig S Fichtlscherer M Vasa M Britten U Kamper S Dimmeler AM Zeiher, Circulation 2005 111 2981 2987 10.1161/CIRCULATIONAHA.104.504340 15927972
45. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. J Yamaguchi KF Kusano O Masuo A Kawamoto M Silver S Murasawa M Bosch-Marce H Masuda DW Losordo JM Isner T Asahara, Circulation 2003 107 1322 1328 10.1161/01.CIR.0000055313. 77510.22 12628955
46. Impaired CXCR4 signaling contributes to the reduced neovascularisation capacity of endothelial progenitor cells from patients with coronary artery disease. DH Walter J Haendeler J Reinhold U Rochwalsky F Seeger J Honold J Hoffmann C Urbich R Lehmann F Arenzana-Seisdesdos A Aicher C Heeschen S Fichtlscherer AM Zeiher S Dimmeler, Circ Res 2005 97 1142 1151 10.1161/01.RES.0000193596.94936.2c 16254213
47. The interleukin-8 pathway in cancer. DJ Waugh C Wilson, Clin Cancer Res 2008 14 6735 6741 10.1158/1078-0432.CCR-07-4843 18980965
48. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. JM Burns BC Summers Y Wang A Melikian R Berahovich Z Miao ME Penfold MJ Sunshine DR Littman CJ Kuo K Wei BE McMaster K Wright MC Howard TJ Schall, J Exp Med 2006 203 2201 2213 10.1084/jem.20052144 16940167
49. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. KH Baek A Zaslavsky RC Lynch C Britt Y Okada RJ Siarey MW Lensch IH Park SS Yoon T Minami JR Korenberg J Folkman GQ Daley WC Aird Z Galdzicki S Ryeom, Nature 2009 459 1126 1130 10.1038/nature08062 19458618
50. Caspase-8 is involved in neovascularization-promoting progenitor cell functions. D Scharner L Rössig G Carmona E Chavakis C Urbich A Fischer TB Kang D Wallach YJ Chiang YL Deribe I Dikic AM Zeiher S Dimmeler, Arterioscler Thromb Vasc Biol 2009 29 571 578 10.1161/ATVBAHA.108.182006 19122169
51. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. Y Wu M Alvarez DJ Slamon P Koeffler JV Vadgama, BMC Cancer 2010 10 32 10.1186/1471-2407-10-32 20132554
52. Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways. C Fiorito M Rienzo E Crimi R Rossiello ML Balestrieri A Casamassimi F Muto V Grimaldi A Giovane B Farzati FP Mancini C Napoli, Free Radic Res 2008 42 754 762 10.1080/10715760802357057 18712633
53. Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease. M Zana Z Janka J Klmn, Neurobiol Aging 2007 28 648 676 10.1016/j.neurobiolaging.2006.03.008 16624449
54. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses. DK Slonim K Koide KL Johnson U Tantravahi JM Cowan Z Jarrah DW Bianchi, Proc Natl Acad Sci USA 2009 106 9425 9429 10.1073/pnas.0903909106 19474297
55. Interferons at age 50: past, current and future impact on biomedicine. EC Borden GC Sen G Uze RH Silverman RM Ransohoff GR Foster GR Stark, Nat Rev Drug Discov 2007 6 975 990 10.1038/nrd2422 18049472
56. Interferon-alpha: regulatory effects on cell cycle and angiogenesis. S Rosewicz K Detjen A Scholz Z von Marschall, Neuroendocrinology 2004 80 85 93 10.1159/000080748 15477724
57. Role of Endogenous Angiogenesis Inhibitors in Down Syndrome. S Ryeom J Folkman, J Craniofac Surg 2009 20 595 596 10.1097/SCS.0b013e3181927f47 19795527
58. Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome. R Lyle C Gehrig C Neergaard-Henrichsen S Deutsch SE Antonarakis, Genome Res 2004 14 1268 1274 10.1101/gr.2090904 15231743
59. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. P Kahlem M Sultan R Herwig M Steinfath D Balzereit B Eppens NG Saran MT Pletcher ST South G Stetten H Lehrach RH Reeves ML Yaspo, Genome Res 2004 14 1258 1267 10.1101/gr.1951304 15231742